tiprankstipranks
Trending News
More News >
Newron Pharmaceuticals SpA (NWPHF)
OTHER OTC:NWPHF

Newron Pharmaceuticals SpA (NWPHF) Similar Stocks

Compare
9 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Newron Pharmaceuticals SpA
$9.36
$352.99M
6.81
0.00%
2 Buy
0 Hold
0 Sell
Moderate Buy
Molecular Partners AG
CHF3.38
$129.20M
-1.97
-30.88%
0 Buy
1 Hold
0 Sell
Hold
Basilea Pharmaceutica
CHF52.30
CHF568.22M
7.80
29.93%
2 Buy
0 Hold
0 Sell
Moderate Buy
Idorsia Ltd
CHF4.11
CHF890.38M
-5.36
208.15%
2 Buy
0 Hold
0 Sell
Moderate Buy
Santhera Pharmaceuticals Holding
CHF12.34
$163.05M
-2.38
27.35%
1 Buy
0 Hold
0 Sell
Moderate Buy
Xlife Sciences Ltd.
CHF25.40
CHF100.93M
3.25
-16.15%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
NWPHF
Newron Pharmaceuticals SpA
9.36
0.00
0.00%
CH:MOLN
Molecular Partners AG
3.38
-1.43
-29.73%
CH:BSLN
Basilea Pharmaceutica
53.40
13.10
32.51%
CH:IDIA
Idorsia Ltd
4.16
2.81
208.15%
CH:SANN
Santhera Pharmaceuticals Holding
12.20
2.95
31.89%
CH:XLS
Xlife Sciences Ltd.
21.80
-4.20
-16.15%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts